HILLARY WALDEISEN: Open Payments
NPI 1770235756 · BOZEMAN, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 14 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $545 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| Caris MPI, Inc. | 1 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Legend Biotech USA Inc. | 1 | $24 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $22 |
| PharmaEssentia USA Corporation | 1 | $21 |
| TerSera Therapeutics LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Aadi Bioscience, Inc. | 1 | $18 |
Products named: MI CANCER SEEK, LIBTAYO, IMFINZI, CARVYKTI, ZYNLONTA, DARZALEX, BESREMI, Xermelo.
Industry payments across MT — which companies pay providers there.
